A20 Advance Modular Patient Monitor

A20 Advance Modular Patient Monitor

Patient Monitoring
A20 Advance Modular Patient Monitor
A20 Advance Modular Patient Monitor

Information

The A20 adopts a semi-modular design with mobility,scalability and ease of use, which can easily meet the clinical needs of routine care and sub-intensive care. https://en.zoncare.com/research_detail/18.html - 13.3-inch touch screen display with 170° ultra-wide viewing angle and resolution up to 1920*1080. - Support touch screen and gesture operation, operation is intuitive, easy and efficient. - ECG: Adopting AEA multi-lead synchronous ECG algorithm (Alpha ECG Algorithm validated by AHA and CSE), it can provide accurate heart rate monitoring,supporting 3-lead, 5-lead and 12-lead ECG monitoring, with automatic recognition of lead types. - SpO2: Adopt advanced zonFAST oximetry technology, with excellent anti-interference ability and weak perfusion ability, the accuracy can reach 2% in the range of 70%-100%, to meet the needs of neonatal oximetry monitoring. - NIBP: Adopting the innovative zonNIBP blood pressure measurement technology, which is certified by the international authoritative BHS, complies with the internationalstandard of ESH, and supports the statistical analysis of ambulatory blood pressure. - Other screen extension function: access to projector, TV and monitor screens via HDMI. - Other bed observationfunction: 15 beds can be monitored centrally withinthe local areanetwork. - Expansion module: CO2 module (mainstream/bypass), wirelessinfrared temperature, recorder.
Wuhan Zoncare Bio-Medical Electronics Co., Ltd.S2.G39Founded in January 2005, Wuhan Zoncare Bio-medical Electronics Co., Ltd. is a National High-tech Enterprise. Zoncare has an independent and complete research and development, procurement, manufacturing, marketing and service system, and is committed to providing high cost-effective products and excellent services for global medical institutions, helping improve medical conditions and reduce medical costs around the world. With R&D centers in Wuhan and Shenzhen, Zoncare has yielded substantial results in Medical Equipment Core technology research. There are around 30% technical staffs service in R&D system. At present, Zoncare has obtained more than 120 patent authorizations, including more than 80 invention patents. As a leading medical device manufacturer, Zoncare dedicates to explore and innovate for improving human health. Zoncare is specializing in ECG machine, ultrasound imaging system, holter, and patient monitor. In addition to China's NMPA registration certification, some products have also obtained EU CE, US FDA 510 (K), Russia GOST-R, Brazil ANVISA and other certifications, which can meet the needs of customers in different countries. Zoncare commits to the exploration, innovation, and development of medical equipment industry, to be the main power to protect the health of human being. During the 17 years development, Zoncare has now established a worldwide sales distribution and service network with branch offices in 27 major cities of China and many strategic cooperation partners around the world. Today, more than 100 countries and regions and nearly 50,000 customers receive and enjoy the services of Zoncare.

Join the event!